Last 48 quarters of trend data · Healthcare · Healthcare Providers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 16.06 | 14.20 | 19.19 | 12.53 | 10.86 | 7.25 | — | 10.96 | 18.16 | 14.70 | — | 15.60 | 8.36 | — | 31.10 | 21.67 | 13.64 | 702.91 | 47.46 | 30.95 | 148.25 |
| — | +95.8% | — | +14.4% | -40.2% | -50.6% | — | -29.8% | +117.1% | — | — | -28.0% | -38.7% | — | -34.5% | -30.0% | -90.8% | +1362.6% | -21.8% | +45.8% | +680.8% | |
| P/S Ratio | 0.89 | 0.74 | 0.92 | 0.71 | 0.73 | 0.67 | 0.60 | 0.42 | 0.49 | 0.48 | 0.46 | 0.55 | 0.45 | 0.47 | 0.66 | 0.62 | 0.53 | 0.54 | 0.76 | 0.81 | 0.79 |
| — | +11.0% | +52.8% | +71.0% | +49.5% | +38.1% | +31.3% | -23.7% | +8.6% | +2.3% | -31.0% | -11.9% | -14.1% | -13.1% | -12.8% | -23.4% | -33.1% | -52.0% | -48.9% | -37.5% | -36.7% | |
| P/B Ratio | 3.48 | 2.67 | 3.34 | 2.57 | 2.68 | 2.49 | 2.31 | 1.45 | 1.72 | 1.69 | 1.66 | 1.95 | 1.68 | 1.76 | 2.47 | 2.35 | 2.09 | 2.13 | 2.96 | 3.09 | 2.92 |
| — | +7.0% | +44.2% | +76.9% | +56.1% | +47.6% | +39.6% | -25.5% | +2.5% | -3.8% | -32.9% | -17.0% | -19.9% | -17.6% | -16.4% | -24.1% | -28.3% | -45.5% | -39.2% | -27.7% | -33.2% | |
| P/FCF | 15.20 | 12.62 | 18.68 | 7.78 | 21.39 | 4.42 | 10.06 | 7.24 | 6.18 | 70.87 | 13.02 | — | 3.99 | 182.24 | 44.07 | — | 10.22 | — | 41.25 | — | 11.06 |
| — | +185.5% | +85.7% | +7.6% | +246.1% | -93.8% | -22.7% | — | +54.9% | -61.1% | -70.5% | — | -61.0% | — | +6.8% | — | -7.6% | — | +67.5% | — | +56.5% | |
| EV / EBITDA | 11.88 | 9.05 | 15.44 | 7.95 | 10.49 | 5.28 | — | 6.78 | 11.08 | 9.16 | 97.60 | 9.12 | 5.39 | — | 21.05 | 15.35 | 9.53 | 51.57 | 23.85 | 18.82 | 59.68 |
| — | +71.2% | — | +17.2% | -5.3% | -42.3% | — | -25.7% | +105.5% | — | +363.6% | -40.6% | -43.4% | — | -11.7% | -18.4% | -84.0% | +76.0% | -22.8% | +35.9% | +355.2% | |
| EV / EBIT | 31.52 | 9.65 | 18.47 | 8.66 | 10.66 | 4.91 | — | 7.09 | 12.37 | 10.23 | — | 9.88 | 5.71 | — | 22.11 | 14.81 | 10.56 | 127.37 | 36.88 | 21.00 | 154.45 |
| — | +96.7% | — | +22.1% | -13.8% | -52.0% | — | -28.2% | +116.8% | — | — | -33.3% | -46.0% | — | -40.1% | -29.4% | -93.2% | +250.8% | +0.4% | +40.1% | +997.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.0% | 16.8% | 15.9% | 16.4% | 16.3% | 20.8% | 0.6% | 15.2% | 13.4% | 14.8% | 9.7% | 15.2% | 17.3% | 8.2% | 14.9% | 14.9% | 13.5% | 9.1% | 10.7% | 12.5% | 10.3% |
| — | -19.3% | +2362.2% | +7.9% | +21.9% | +40.2% | -93.4% | -0.4% | -22.8% | +80.1% | -34.8% | +2.4% | +28.5% | -9.3% | +39.5% | +18.6% | +31.3% | -25.8% | -31.0% | -28.1% | -38.7% | |
| Operating Margin | 2.6% | 6.7% | 4.7% | 7.3% | 5.5% | 10.7% | -9.1% | 4.8% | 3.3% | 4.4% | -0.4% | 5.1% | 7.4% | -1.3% | 2.4% | 3.2% | 4.7% | 0.2% | 2.3% | 3.3% | 0.4% |
| — | -37.6% | +152.0% | +52.0% | +67.9% | +141.3% | -2254.2% | -6.2% | -55.9% | +449.3% | -116.3% | +57.8% | +57.7% | -932.6% | +2.1% | -1.1% | +1119.9% | -94.6% | -37.0% | -58.7% | -95.3% | |
| Net Margin | 3.2% | 5.2% | 4.8% | 5.6% | 6.7% | 9.3% | -7.1% | 3.8% | 2.7% | 3.3% | -0.4% | 3.6% | 5.3% | -1.3% | 2.0% | 2.8% | 3.8% | 0.1% | 1.6% | 2.7% | 0.5% |
| — | -43.9% | +168.3% | +46.3% | +145.9% | +182.3% | -1583.2% | +6.4% | -48.9% | +345.4% | -121.3% | +29.2% | +39.9% | -1818.8% | +22.7% | +5.4% | +661.1% | -96.6% | -33.2% | -56.1% | -92.4% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.7% | 4.7% | 4.4% | 5.1% | 6.2% | 8.8% | -6.5% | 3.4% | 2.4% | 2.9% | -0.4% | 3.3% | 5.0% | -1.2% | 1.9% | 2.7% | 3.8% | 0.1% | 1.5% | 2.5% | 0.5% |
| — | -46.3% | +167.3% | +49.8% | +157.5% | +202.1% | -1627.6% | +3.3% | -52.1% | +337.3% | -120.4% | +22.1% | +32.0% | -1744.1% | +20.1% | +6.9% | +744.2% | -96.2% | -20.9% | -50.3% | -92.3% | |
| ROA | 7.3% | 3.0% | 2.8% | 3.2% | 3.9% | 5.3% | -4.0% | 2.1% | 1.5% | 1.7% | -0.2% | 1.9% | 2.9% | -0.7% | 1.1% | 1.6% | 2.2% | 0.0% | 0.9% | 1.5% | 0.3% |
| — | -44.3% | +169.7% | +52.7% | +163.6% | +206.0% | -1686.1% | +10.4% | -49.4% | +340.6% | -120.0% | +17.3% | +29.6% | -1751.1% | +21.5% | +9.9% | +742.2% | -96.3% | -23.2% | -52.8% | -92.6% | |
| ROIC | 9.0% | 6.0% | 4.3% | 6.6% | 5.0% | 9.6% | -7.4% | 3.6% | 2.3% | 2.9% | -0.3% | 3.6% | 5.1% | -0.8% | 1.6% | 2.3% | 3.4% | 0.1% | 1.7% | 2.5% | 0.3% |
| — | -37.2% | +158.2% | +82.3% | +116.8% | +232.7% | -2791.6% | +2.3% | -55.1% | +448.4% | -116.3% | +57.3% | +50.1% | -857.2% | -8.0% | -10.5% | +1049.6% | -95.1% | -40.8% | -61.7% | -95.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.03 | 0.03 | 0.03 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.07 | 0.09 | 0.11 | 0.10 | 0.13 | 0.11 | 0.10 | 0.08 | 0.08 | 0.05 | 0.05 | 0.04 |
| — | -16.1% | +6.2% | +84.5% | +47.1% | -41.9% | -62.7% | -85.5% | -65.6% | -45.7% | -24.6% | +7.8% | +23.1% | +60.4% | +152.3% | +114.6% | +97.5% | +225.4% | +90.1% | +85.2% | +13.4% | |
| Debt / EBITDA | 0.38 | 0.50 | 0.69 | 0.39 | 0.84 | 0.37 | — | 0.31 | 0.92 | 1.50 | 19.95 | 2.00 | 1.25 | — | 3.82 | 2.52 | 1.40 | 7.62 | 1.48 | 1.13 | 3.35 |
| — | +33.8% | — | +24.5% | -8.8% | -75.0% | — | -84.4% | -26.1% | — | +422.1% | -20.6% | -11.3% | — | +158.7% | +122.7% | -58.1% | +897.3% | +132.1% | +232.7% | +658.4% | |
| Current Ratio | 3.38 | 2.82 | 3.02 | 3.11 | 3.38 | 2.97 | 2.49 | 2.89 | 2.89 | 2.93 | 2.74 | 2.77 | 2.64 | 2.84 | 2.90 | 3.15 | 2.85 | 2.82 | 2.84 | 3.01 | 2.86 |
| — | -4.9% | +21.5% | +7.5% | +17.0% | +1.2% | -9.1% | +4.4% | +9.7% | +3.2% | -5.5% | -11.9% | -7.5% | +0.7% | +2.0% | +4.5% | -0.4% | -23.4% | -15.1% | -22.7% | -19.0% | |
| Quick Ratio | 3.28 | 2.82 | 2.94 | 3.03 | 3.28 | 2.88 | 2.41 | 2.81 | 2.80 | 2.85 | 2.65 | 2.69 | 2.55 | 2.74 | 2.79 | 3.02 | 2.73 | 2.69 | 2.71 | 2.87 | 2.72 |
| — | -2.0% | +22.1% | +7.9% | +17.1% | +1.2% | -9.2% | +4.5% | +10.0% | +3.9% | -5.0% | -11.1% | -6.6% | +1.6% | +3.0% | +5.3% | +0.2% | -23.1% | -14.9% | -22.4% | -18.3% | |
| Interest Coverage | 43.95 | — | — | 94.63 | 77.34 | 70.97 | -99.21 | 61.49 | 13.57 | 13.15 | -0.16 | 11.68 | 16.08 | -1.97 | 6.71 | 10.23 | 17.24 | 2.24 | 19.54 | 32.00 | 5.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HCSG stock.
Healthcare Services Group, Inc.'s current P/E is 16.1x. The average P/E over the last 4 quarters is 14.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Healthcare Services Group, Inc.'s current operating margin is 2.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Healthcare Services Group, Inc.'s business trajectory between earnings reports.